| Formulary assessment – estradiol/progesterone (Bijuve) for HRT |
Formulary assessment tools |
May 2022 |
| Estradiol / progesterone (Bijuve®) for hormone replacement therapy in postmenopausal women |
New Drug Evaluations |
May 2022 |
| Formulary assessment – estradiol spray (Lenzetto) |
Formulary assessment tools |
May 2022 |
| Formulary assessment – testosterone 2% gel (Tostran) in post-menopausal women |
Formulary assessment tools |
May 2022 |
| Insulin aspart Sanofi (Trurapi): Biosimilar Insulin Aspart |
Evaluation report |
March 2022 |
| Estradiol spray for the treatment of menopausal symptoms |
New Drug Evaluations |
February 2022 |
| Drugs affecting bone metabolism |
Prescribing Data Report |
August 2021 |
| Fast acting insulin lispro for the treatment of diabetes mellitus |
New Drug Evaluations |
February 2021 |
| Drugs used in Diabetes |
Prescribing Data Report |
June 2022 |
| Cardiovascular outcomes associated with SGLT2 inhibitors (update 2) |
Medicines in Practice |
December 2020 |
